Jacqueline V. Aredo

Cancer Prevention Institute of California

Also affiliated with Stanford Medicine, Stanford Cancer Institute, Stanford University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Tobacco Smoking and Risk of Second Primary Lung Cancer”.

Tobacco Smoking and Risk of Second Primary Lung Cancer

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.02.024

N/A

3.6DataRank · unranked

131 citations

Sophia J. Luo, Rebecca M. Gardner, Nilotpal Sanyal, Eunji Choi, Thomas Hickey +20 more

Widespread myofascial dysfunction and sensitisation in women with endometriosis‐associated chronic pelvic pain: A cross‐sectional study

European Journal of Pain(2020)10.1002/ejp.1713

N/A

2.3DataRank · unranked

60 citations

Pamela Stratton, Hannah Tandon, Ninet Sinaii, Jacqueline V. Aredo, Barbara I. Karp +3 more

Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: A Phase II Multicenter Study

Journal of Clinical Oncology(2024)10.1200/jco.24.00071

N/A

1.4DataRank · unranked

60 citations

Anatoly Urisman, Matthew A. Gubens, Claire K. Mulvey, Greg M. Allen, Stephen Shiboski +19 more

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1420

N/A

0.787DataRank · unranked

189 citations

Haniel A. Araújo, Giuseppe Lamberti, Alissa J. Cooper, Neal S. Akhave, Teng Zhou +61 more

Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.01.1628

N/A

0.731DataRank · unranked

130 citations

Isa Mambetsariev, Jessica A. Hellyer, Arya Amini, Joel W. Neal, Sukhmani K. Padda +11 more

Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.01.012

N/A

0.571DataRank · unranked

44 citations

So Yeon Kim, Jacqueline V. Aredo, Jamie Feng, Frances A. Shepherd, Chao Xu +52 more

Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3497

N/A

0.564DataRank · unranked

42 citations

Jacqueline V. Aredo, Jacqueline H. Starrett, Paul Stockhammer, Iris K. van Alderwerelt van Rosenburgh, Anna Wurtz +16 more

The Survival Impact of Second Primary Lung Cancer in Patients With Lung Cancer

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab224

N/A

0.489DataRank · unranked

25 citations

Sophia J. Luo, Jacqueline V. Aredo, Leah M. Backhus, Lynne R. Wilkens, Chloe C. Su +6 more

Efficacy of osimertinib in patients with EGFR mutant lung cancer harboring the uncommon exon 19 deletion, L747_A750>P.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e21112

N/A

0DataRank · unranked

0 citations

Jacqueline V. Aredo, Jacqueline H. Starrett, Anna Wurtz, Zofia Piotrowska, Andrew J. Piper‐Vallillo +13 more

Smoking Cessation After Lung Cancer Diagnosis and the Risk of Second Primary Lung Cancer: The Multiethnic Cohort Study

JNCI Cancer Spectrum(2021)10.1093/jncics/pkab076

N/A

0DataRank · unranked

9 citations

Eunji Choi, Jacqueline V. Aredo, Lynne R. Wilkens, Martin C. Tammemägi, Loı̈c Le Marchand +4 more

Racial and Ethnic Disparities in Lung Cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort Study

JNCI Cancer Spectrum(2022)10.1093/jncics/pkac033

N/A

0DataRank · unranked

48 citations

Eunji Choi, Victoria Y. Ding, Martin C. Tammemägi, Kevin ten Haaf, Sophia J. Luo +9 more

Risk model‐based management for second primary lung cancer among lung cancer survivors through a validated risk prediction model

Cancer(2023)10.1002/cncr.35069

N/A

0DataRank · unranked

9 citations

Sophia J. Luo, Victoria Y. Ding, Julie Wu, Ashok V. Kumar, Jason A. Wampfler +15 more

Development and Validation of a Risk Prediction Model for Second Primary Lung Cancer

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab138

N/A

0DataRank · unranked

16 citations

Nilotpal Sanyal, Victoria Y. Ding, Rebecca M. Gardner, Jacqueline V. Aredo, Justin Lee +15 more

A Moving Target: Integration of Smoking Cessation Into Screening for Second Primary Lung Cancer

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.05.008

N/A

0DataRank · unranked

0 citations

Heather A. Wakelee, Summer S. Han, Jacqueline V. Aredo